Publications by authors named "Maria Bangher"
Article Synopsis
- - The study aimed to find opportunities for improving antibiotic stewardship (AS) in medical-surgical intensive care units (MS-ICUs) and general wards (Gral-wards) across 41 hospitals in Latin America from March 2022 to February 2023.
- - Data was collected on antimicrobial use (AU) from 5780 MS-ICU and 7726 Gral-ward patients, revealing a 53.5% AU prevalence in MS-ICUs and 25.5% in Gral-wards, with a significant portion of antibiotics used for treating infections and surgical prophylaxis.
- - The study highlighted key areas for improvement in AU practices, including better antibiotic selection, the need for de
Background: Infection prevention and control (IPC) programs are essential to prevent and control the spread of multidrug-resistant organisms in healthcare facilities (HCFs). The current implementation of these programs in Latin America remains largely unknown.
Methods: We conducted a mixed-methods evaluation of IPC program implementation in HCFs from Guatemala, Panama, Ecuador, and Argentina, March-July 2022.
Article Synopsis
- Limited information exists on healthcare workers' views about infection prevention and control (IPC) in Latin America, prompting a survey conducted across 30 hospitals in the region.
- The survey, completed by 1,340 healthcare workers, revealed high self-reported compliance with hand hygiene and prevention measures, but a notable gap in perceived peer compliance.
- Findings highlighted the need for enhanced training and awareness among healthcare workers, particularly physicians, regarding IPC practices and healthcare-associated infection (HAI) rates.
Background: Information about COVID infection in physicians is limited. This knowledge would allow the implementation of actions to reduce its impact. The objective was determining the incidence of SARSCoV-2 infection in physicians from health institutions in Argentina, its characteristics, and associated factors.
View Article and Find Full Text PDFBackground: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients.
Objective: To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19.
Objectives: To assess the efficacy of ivermectin in addition to standard treatment compared to standard treatment alone in reducing hospitalizations in the COVID-19 patient population.
Trial Design: IVERCOR-COVID19 will be a single-center, prospective, randomized, double-blind, parallel group (1:1 ratio), placebo-controlled study.
Participants: Patients who meet the following criteria will be invited to participate: Inclusion criteria: (1) Over 18 years of age who reside in the province of Corrientes at the time of diagnosis.
Clostridioides difficile infections (CDI) are among the leading causes of health care-associated infections. The epidemiology of CDI has undergone major changes in the last decade, showing an increase in incidence, severity, and rate of relapse. These guidelines were developed by specialists from four scientific societies: Sociedad Argentina de Infectología (SADI), Sociedad Argentina de Gastroenterología (SAGE), Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas (SADEBAC) and Asociación de Enfermeras en Control de Infecciones (ADECI).
View Article and Find Full Text PDFBackground: The 2009 novel influenza A/H1N1 virus pandemic did not spare solid organ transplant (SOT) recipients. We aimed to describe the behavior of pandemic influenza infection in a group of SOT recipients in Argentina.
Methods: Data from 10 transplant (Tx) centers were retrospectively collected for SOT that presented with a respiratory illness compatible with pandemic influenza A infection, between May and September 2009.